Type2diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with type 2 diabetes. 2. Age more than 20 3. Under treatment with no antidiabetic agents, or with oral hypoglycemic drugs. 4. Patients with Hb1c less than 8.5% at entry.
Exclusion criteria
Exclusion criteria: 1. Complication by stage 3A or more severe diabetic nephropathy, or stage 3 or more severe chronic kidney disease(CKD)not associated with diabetes. 2. Malignant or acute disease 3. Severe liver disease 4. Decreased pancreatic function due to chronic pancreatitis 5. Hyperthyroidism 6. Adrenal insufficiency 7. Under steroid treatment 8. Patients judged to have difficulty in performing diabetics on his/her own due to dementia etc. 9. Other patients judged unsuitable by the attending physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in HbA1c | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Change in fasting plasma glucose,1,5-Anhydroglucitol,glycated albumin,fasting plasma insulin 2. Change in body weight,waist circumference,body composition and basal energy expenditure. 3. Change in Lipid profile(LDL-C,HDL-C,TG) 4. Level of performance of dietary management(intake energy and nutrition survey) 5. Level of satisfaction with therapy,quality of life(questionary survey) | — |
Countries
Japan
Contacts
Yokohama City University Graduate School of Medicine Department of Endocrinology and Metabolism